Star Combo Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Star Combo Pharma has a total shareholder equity of A$33.5M and total debt of A$9.3K, which brings its debt-to-equity ratio to 0.03%. Its total assets and total liabilities are A$42.8M and A$9.3M respectively. Star Combo Pharma's EBIT is A$922.5K making its interest coverage ratio -14.2. It has cash and short-term investments of A$7.4M.
Key information
0.03%
Debt to equity ratio
AU$9.29k
Debt
| Interest coverage ratio | -14.2x |
| Cash | AU$7.36m |
| Equity | AU$33.51m |
| Total liabilities | AU$9.30m |
| Total assets | AU$42.82m |
Recent financial health updates
Recent updates
Some Star Combo Pharma Limited (ASX:S66) Shareholders Look For Exit As Shares Take 31% Pounding
Nov 11
Star Combo Pharma Limited's (ASX:S66) 30% Share Price Surge Not Quite Adding Up
Aug 23Star Combo Pharma (ASX:S66) Might Have The Makings Of A Multi-Bagger
Aug 13Star Combo Pharma Limited's (ASX:S66) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 12Star Combo Pharma (ASX:S66) Is Doing The Right Things To Multiply Its Share Price
May 12Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon
Mar 20Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?
Nov 21Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think
Mar 02Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt
Dec 24
Financial Position Analysis
Short Term Liabilities: S66's short term assets (A$18.4M) exceed its short term liabilities (A$4.9M).
Long Term Liabilities: S66's short term assets (A$18.4M) exceed its long term liabilities (A$4.4M).
Debt to Equity History and Analysis
Debt Level: S66 has more cash than its total debt.
Reducing Debt: S66's debt to equity ratio has reduced from 0.3% to 0.03% over the past 5 years.
Debt Coverage: S66's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: S66 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 04:51 |
| End of Day Share Price | 2024/12/13 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Star Combo Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|